Evidence map›Paper›PMID 31620310›Full record

ArticleJournal of pathology informatics2019

The California Telepathology Service: UCLA's Experience in Deploying a Regional Digital Pathology Subspecialty Consultation Network.

Thomas Chong, M Fernando Palma-Diaz, Craig Fisher, Dorina Gui, Nora L Ostrzega, Geoffrey Sempa, Anthony E Sisk, Mark Valasek, Beverly Y Wang, Jonathan Zuckerman and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of pathology informatics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Review
  6. The Critical Value of Telepathology in the COVID-19 Era.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Integrating digital pathology into clinical practice.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Review
  11. Measuring Digital Pathology Throughput and Tissue Dropouts.Journal of pathology informatics · 2022
    Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Validation of a digital pathology system including remote review during the COVID-19 pandemic.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2020
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Thomas ChongDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
M Fernando Palma-DiazKaiser Permanente Los Angeles Medical Center, Department of Pathology, Los Angeles, CA, USA.
Craig FisherUCSD Medical Center Pathology, San Diego, CA, USA.
Dorina GuiDepartment of Pathology and Laboratory Medicine, University of California, Sacramento, CA, USA.
Nora L OstrzegaDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Geoffrey SempaDepartment of Pathology and Laboratory Medicine, UC Irvine School of Medicine, Irvine, CA, USA.
Anthony E SiskDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Mark ValasekUCSD Medical Center Pathology, San Diego, CA, USA.
Beverly Y WangDepartment of Pathology and Laboratory Medicine, UC Irvine School of Medicine, Irvine, CA, USA.
Jonathan ZuckermanDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Chris KhacherianDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Scott BinderAffiliated Pathologists Medical Group, Inc., Rancho Dominguez, CA, USA.
W Dean WallaceDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
University of California, Los Angeles · USUniversity of California, Irvine · USUniversity of California San Diego Medical Center · USCalifornia State University, Sacramento · USCardiovascular Medical Group · USKaiser Permanente · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe need for extending pathology diagnostic expertise to more areas is now being met by the maturation of technology that can effectively deliver this level of care. The experience and lessons learned from our successfully deployed International Telepathology Service (ITS) to a hospital system in China guided us in starting a domestic telepathology network, the California Telepathology Service (CTS). Many of the lessons learned from the ITS project informed our decision-making for the CTS. New challenges were recognized and overcome, such as addressing the complexity and cost-benefit tradeoffs involved in setting up a digital consultation system that competes with an established conventional glass slide delivery system.

methodsThe CTS is based on a hub-and-spoke telepathology network using Leica Biosystems whole-slide image scanners and the eSlide Manager (eSM Version 12.3.3.7055, Leica Biosystems) digital image management software solution. The service currently comprises six spoke sites (UC San Diego [UCSD], UC Irvine [UCI], UC Davis, Northridge Hospital Medical Center [NHMC], Olive View Medical Center [OVMC], and Children's Hospital Los Angeles) and one central hub site (UCLA Medical Center). So far, five sites have been validated for telepathology case consultations following established practice guidelines, and four sites (UCI, UCSD, NHMC, and OVMC) have activated the service.

resultsFor the active spoke sites, we reviewed the volume, turnaround time (TAT), and case types and evaluated for utility and value. From May 2017 to July 2018, a total of 165 cases were submitted. Of note, digital consultations were particularly advantageous for preliminary kidney biopsy diagnoses (avg TAT 0.7 day).

conclusionFor spoke sites, telepathology provided shortened TAT and significant financial savings over hiring faculty with expertise to support a potentially low-volume service. For the hub site, the value includes exposure to educationally valuable cases, additional caseload volume to support specialized services, and improved communication with referring facilities over traditional carrier mail. The creation of a hub-and-spoke telepathology network is an expensive undertaking, and careful consideration needs to be given to support the needs of the clinical services, acquisition and effective deployment of the appropriate equipment, network requirements, and laboratory workflows to ensure a successful and cost-effective system.

Indexed as

Digital pathologytelemedicinetelepathologywhole slide imaging

Identifiers

PMID31620310
PMCPMC6788184
OpenAlexW2976218146

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.